ENDEAVOR
Striving to improve the quality of life of Barrett’s Esophagus patients.
Welcome
WHAT is the ENDEAVOR research project?
ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.
Welcome
WHAT is the ENDEAVOR research project?
ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.


















Funded by the European Union
* Disclaimer: “Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.”
💥 In her first blog, ENDEAVOR PhD candidate Costanza Di Patrizi, from the University of Antwerp, explains more about her own research focused on quality of life and patient-centered care.
Interested? Read more on
#EUfunded #ClinicalResearch
💥 In her first blog, ENDEAVOR PhD candidate Nastaran Riahi highlights the importance of the #ENDEAVOReu study and explains more about her own research focused on cfDNA methylation.
Interested? Read more on
#EUfunded #ClinicalResearch
💥 In his first blog, ENDEAVOR researcher and PhD candidate Henrik Maltzman highlights the importance of the #ENDEAVOReu study and explains more about his own research.
👀Interested? Read more on
#EUfunded #Blog #ClinicalResearch
